Estimating the optimal perioperative chemotherapy utilization rate for muscle-invasive bladder cancer.

ABSTRACT:

Background

Identifying optimal chemotherapy (CT) utilization rates can drive improvements in quality of care. We report a benchmarking approach to estimate the optimal rate of perioperative CT for muscle-invasive bladder cancer (MIBC).

Methods

The Ontario Cancer Registry and linked treated records were used to identify neoadjuvant and adjuvant CT rates among patients with MIBC during 2004-2013. Monte Carlo simulation was used to estimate the proportion of observed rate variation that could be due to chance alone. The criterion-based benchmarking approach was used to explore whether social and health-system factors were associated with CT rates. We also used the "pared-mean" approach to identify a benchmark population of hospitals with the highest treatment rates. Hospital CT

SUBMITTER: Karim S 

PROVIDER: S-EPMC6797575 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature